Join Aitia at Charles River’s sixth Annual World Congress

We are excited to announce that Colin Hill will be speaking at Charles River’s sixth Annual World Congress on May 11, 2023, in Cambridge, MA. Colin’s session will focus on “Al and Digital Twins to Drive the Next Generation of Drug Discovery and Development”. The presentation will be followed by a fireside chat with Julie […]

Join Aitia and our Partner GAP at the American Academy of Neurology Annual Meeting 2023

We are excited to announce our attendance at the American Academy of Neurology Annual Meeting 2023, which will be held in Boston. As we look forward to this event, we are also pleased to be joined by our strategic partner the Global Alzheimer’s Platform Foundation (GAP). Together, we are committed to advancing the field of […]

Join Aitia at the Pistoia Alliance Annual Spring Conference

We are excited to be attending the Pistoia Alliance Annual Spring Conference. This year’s theme is Collaborate to Innovate, and we can’t wait to explore the opportunities for pre-competitive collaboration in the life sciences industry. Let’s connect and discuss the challenges and possibilities for innovation and AI adoption in R&D. Come meet us there and […]

Companies to Focus on Therapeutic Targets Showing Cause and Effect

Aitia has been featured in Huntington’s Disease News for its collaboration with UCB to develop a new treatment for Huntington’s disease. The article highlights Aitia’s expertise in Causal AI as “a new branch of artificial intelligence that goes beyond establishing links between variables: It makes decisions and predictions based on cause and effect.” The collaboration […]

UCB Enters Drug Discovery Collaboration with Aitia

Aitia latest strategic drug discovery collaboration with UCB, focused on the discovery and validation of novel drug targets and drug candidates for Huntington’s disease. The collaboration will combine the use of new drug targets for Huntington’s disease from Aitia’s Gemini Digital Twins with the expertise of UCB in preclinical model systems and drug research in neurodegeneration for advancing […]

Aitia Announces Oral Poster Presentation and Abstract at AACR

Aitia is looking forward to attend this year’s American Association for Cancer Research meeting #AACR23 taking place in Orlando, Florida, on April 14-19. Our team will be presenting a poster with our new results from our Multiple Myeloma Digital Twins model. Details of the poster session: Title: Infer cancer cell gene dependency in multiple myeloma using causal AI in-silico patient […]

Aitia Announces its Participation in the Upcoming AD/PD™ 2023 in Gothenburg, Sweden

Aitia is excited to announce its participation in the upcoming AD/PD™ 2023, a global conference on Alzheimer’s and Parkinson’s Diseases, to be held in Gothenburg, Sweden from March 28 – April 1.If you are interested in learning more about Aitia’s latest breakthroughs, particularly in the field of Alzheimer’s disease, we encourage you to schedule a […]

Join Aitia at BIO-Europe Spring 2023 in Basel, Switzerland

Aitia team will be attending the 17th annual BIO-Europe Spring conference in Basel, Switzerland, from March 20 to March 22, 2023. This event brings together over 2,800 executives from the biopharmaceutical industry, and we are excited to meet with fellow industry leaders to exchange ideas, forge new partnerships, and advance our shared goal of improving […]

Richard Harrison to Present at the Lab of the Future Congress

The Lab of the Future Congress USA is returning to Boston on March 9th and 10th 2023, and Team Aitia will be there to share our expertise on how Digital Twins are revolutionizing the drug discovery process and validating novel targets. Don’t miss the opportunity to attend our informative session on March 10th at 11:50 […]

Meet us at GAP Net Site Optimization Conference

If you are attending the upcoming GAP Net Site Optimization Conference in Austin, TX from Feb 24-26, join us for thought-provoking discussions on advancing Alzheimer’s disease clinical development. This conference will bring together the nation’s leading Alzheimer’s disease clinical trial research centers and GAP-Net partners to discuss the most recent advancements, challenges, and best practices […]